StockData

Neutra Corp. (NTRR) stock

NTRROTCMedicinal Chemicals & Botanical ProductsFiscal year ends January 31
Financials through Q3 FY2024, quarter ended Oct 31, 2023Last filing: 10-Q on Aug 7, 2024
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Neutra revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Neutra's revenue for the twelve months ending Oct 31, 2023 was $17.40K, down 82.7% year over year. For fiscal 2023 it was $68.00K, down 26.1% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2023Jan 31, 2023$68.00K-26.1%
FY2022Jan 31, 2022$92.01K+849.9%
FY2021Jan 31, 2021$9.69K+51.5%
FY2020Jan 31, 2020$6.40K–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2024CQ3 2023Oct 31, 2023$1.31K-94.4%
Q2 FY2024CQ2 2023Jul 31, 2023$4.33K-85.1%
Q1 FY2024CQ1 2023Apr 30, 2023$5.84K-39.5%
Q4 FY2023CQ4 2022Jan 31, 2023$5.92K-84.6%
Q3 FY2023CQ3 2022Oct 31, 2022$23.38K-11.0%
Q2 FY2023CQ2 2022Jul 31, 2022$29.03K+83.7%
Q1 FY2023CQ1 2022Apr 30, 2022$9.66K-16.4%
Q4 FY2022CQ4 2021Jan 31, 2022$38.38K+1629.0%
Q3 FY2022CQ3 2021Oct 31, 2021$26.27K+3518.6%
Q2 FY2022CQ2 2021Jul 31, 2021$15.81K+326.6%
Q1 FY2022CQ1 2021Apr 30, 2021$11.55K+280.5%
Q4 FY2021CQ4 2020Jan 31, 2021$2.22K–
Q3 FY2021CQ3 2020Oct 31, 2020$726–
Q2 FY2021CQ2 2020Jul 31, 2020$3.71K+84.7%
Q1 FY2021CQ1 2020Apr 30, 2020$3.04K–
Q3 FY2019CQ3 2018Oct 31, 2018$0–
Q2 FY2019CQ2 2018Jul 31, 2018$0–
Q1 FY2019CQ1 2018Apr 30, 2018$2.01K–

More Neutra figures

See a number that looks wrong?